Study of Tacrolimus Immunosuppressive Therapy After Kidney Transplantation

NCT00717379 · clinicaltrials.gov ↗
PHASE4
Phase
COMPLETED
Status
50
Enrollment
INDUSTRY
Sponsor class

Conditions

Interventions

Sponsor

Astellas Pharma Inc